IRCT20210928052621N1 IRCT 2023-09-04 Islamic Azad University The effect of omega-3 on Diabet The effect of omega-3 fatty acids on Glycemic control in type 2 diabetic patients 2023-09-11 anticipated 188 Complete https://irct.ir/trial/71818 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Due to the double-blindness of this study, the drugs used for the patients were divided by the head of the department in A/B form at the beginning of the study so that the researcher and the participants did not know the type of drug received. For randomization, each patient was first given a number from 1 to 188, then using online random numbers from 1 to 188, 94 numbers were randomly generated. Patients with these numbers were in the treatment group and patients with The remaining numbers were placed in the control group, Blinding description: The doctor is unaware of the study groups, the patient is unaware of the study groups, the researcher is unaware of the study groups, the data analyst is unaware of the study groups .The division of patients into drug and placebo groups is done by a nurse outside of the above groups. 3 diabet type 2. Intervention 1: Intervention group: In the intervention group, 3000 mg of omega-3 fatty acid (3 capsules of 1000 mg in the morning, noon, and night from Dana Pharmaceutical Company under the brand name Omega Rex) was given for 12 weeks. Intervention 2: Control group: The placebo control group (containing 300 mg of polyunsaturated fatty acid, 100 mg of unsaturated fatty acid and 600 mg of linoleic acid) was given 3 times a day for 12 weeks. No - There is not a plan to make this available Justification or reason for not sharing IPD is The intervention was conducted on a small number of samples, and to draw conclusions, a large sample size and more facilities are needed, which were not possible in this trial.